|
| 37995597 | Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network. | Eur J Cancer | 2024 |
| 38061151 | European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO. | Eur J Surg Oncol | 2024 |
| 36560842 | Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis. | Br J Surg | 2023 |
| 37528842 | The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus. | EClinicalMedicine | 2023 |
| 37633095 | Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis. | Eur J Cancer | 2023 |
| 37660517 | Intraoperative ultrasound margin evaluation as a tool to reduce positive superficial margins in nipple and skin sparing mastectomy in breast cancer patients. | Eur J Surg Oncol | 2023 |
| 37146504 | European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care. | Eur J Cancer | 2023 |
| 37244843 | Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment. | Eur J Surg Oncol | 2023 |
| 37126938 | Uncertainties and controversies in axillary management of patients with breast cancer. | Cancer Treat Rev | 2023 |
| 36400101 | European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission. | Lancet Oncol | 2023 |
| 36641897 | EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy. | Eur J Cancer | 2023 |
| 36801149 | Gender disparities in surgery - a global perspective. | Eur J Surg Oncol | 2023 |
| 36898258 | Real de-escalation or escalation in disguise? | Breast | 2023 |
| 34748122 | Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry. | Ann Surg Oncol | 2022 |
| 35766257 | Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey. | Br J Surg | 2022 |
| 35396137 | Four-fraction ultra-accelerated minimal breast irradiation in early breast cancer: The initial feasibility results of an institutional experience. | Brachytherapy | 2022 |
| 35366506 | Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy. | Breast | 2022 |
| 35760079 | Intraoperative Ultrasound-Guided Excision of Non-Palpable and Palpable Breast Cancer: Systematic Review and Meta-Analysis. | Ultraschall Med | 2022 |
| 36590147 | Current Evolutions in Axillary Management. | Breast Care (Basel) | 2022 |
| 35954357 | Intra-Operative Electron Radiation Therapy: An Update of the Evidence Collected in 40 Years to Search for Models for Electron-FLASH Studies. | Cancers (Basel) | 2022 |
| 36007873 | How to improve efficiency in cancer care: Dimensions, methods, and areas of evaluation. | J Cancer Policy | 2022 |
| 34996668 | Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning. | Breast | 2022 |
| 32912619 | Erratum to "Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": Annals of Oncology 30; 2019: 1194-1220. | Ann Oncol | 2021 |
| 33805367 | Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study. | Cancers (Basel) | 2021 |
| 33721561 | 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age. | Lancet Oncol | 2021 |
| 34824288 | Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial. | NPJ Breast Cancer | 2021 |
| 34544554 | Adenoid cystic carcinoma and basaloid carcinoma of the breast: A clinicopathological study. | Rev Esp Patol | 2021 |
| 34099718 | The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. | NPJ Breast Cancer | 2021 |
| 34312396 | Evaluation of multiple transcriptomic gene risk signatures in male breast cancer. | NPJ Breast Cancer | 2021 |
| 33475291 | Local Treatment of Triple-Negative Breast Cancer. | Cancer J | 2021 |
| 33387500 | Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. | Lancet Oncol | 2021 |
| 33002230 | Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments. | J Surg Oncol | 2021 |
| 32565894 | Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic? | Ecancermedicalscience | 2020 |
| 31785986 | Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment. | Eur J Surg Oncol | 2020 |
| 32083990 | Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial. | J Clin Oncol | 2020 |
| 31833973 | Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019. | Curr Opin Obstet Gynecol | 2020 |
| 32075718 | Theoretical and practical knowledge curriculum for European Breast Surgeons. | Eur J Surg Oncol | 2020 |
| 33224883 | Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals. | Front Oncol | 2020 |
| 33437299 | Minimally invasive tumor bed implant (MITBI) and peri-operative high-dose-rate brachytherapy (PHDRBT) for accelerated minimal breast irradiation (AMBI) or anticipated boost (A-PHDRBT-boost) in breast-conserving surgery for ductal carcinoma in situ. | J Contemp Brachytherapy | 2020 |
| 32919301 | Axillary staging based on molecular analysis: Results of the B-CLOSER-II study. | Pathol Res Pract | 2020 |
| 32631710 | A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study. | Eur J Surg Oncol | 2020 |
| 32217457 | The requirements of a specialist breast centre. | Breast | 2020 |
| 32199592 | Basaloid squamous cell carcinoma of the breast. | Rev Esp Patol | 2020 |
| 30638809 | Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey. | Eur J Surg Oncol | 2019 |
| 31933582 | Education and Training in Breast Cancer Surgery in Europe. | Breast Care (Basel) | 2019 |
| 31933581 | European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes. | Breast Care (Basel) | 2019 |
| 31706464 | Corrigendum to "About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position" [Breast 46 (August 2019) 95-96]. | Breast | 2019 |
| 31706463 | Corrigendum to "EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants" [Breast 44 (April 2019) 90-93]. | Breast | 2019 |
| 31525579 | Transforming Breast Cancer Together: European elections manifesto 2019 seizing the opportunities for breast cancer patients. | Breast | 2019 |
| 31236598 | Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2019 |